Automation/Robot

PUBLISHER: 360iResearch | PRODUCT CODE: 2088850

PUBLISHER: 360iResearch | PRODUCT CODE: 2088850

Robotic Nurse Assistant Market by Component, Mobility, Autonomy Level, Application, End User - Global Forecast 2026-2032

PUBLISHED: July 14, 2026

PAGES: 189 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Robotic Nurse Assistant Market is projected to grow by USD 3.88 billion at a CAGR of 15.06% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.45 billion
Estimated Year [2026]	USD 1.68 billion
Forecast Year [2032]	USD 3.88 billion
CAGR (%)	15.06%

Robotic Nurse Assistant Market Introduction

Robotic nurse assistants are moving from pilot projects to operational tools as hospitals, long-term care providers, and rehabilitation centers confront persistent staffing pressure, aging populations, and higher acuity care. The World Health Organization has warned of a global health workforce shortfall risk by 2030, while many high-income health systems continue to manage nurse burnout, vacancy rates, and rising demand for bedside support.

The robotic nurse assistant landscape includes mobile service robots, autonomous transport systems, patient lifting and transfer robots, telepresence units, medication and supply delivery platforms, disinfection support robots, and AI-enabled monitoring assistants. Demand is strongest where robotic nurse assistant solutions can reduce non-clinical workload, improve response times, support infection prevention, lower manual handling risks, and extend clinical staff capacity without replacing licensed nursing judgment.

Transformative Shifts in Robotic Nursing

The robotic nurse assistant landscape is shifting from single-purpose automation toward integrated clinical workflow support. Hospitals are prioritizing robots that connect with electronic health records, nurse call systems, pharmacy workflows, asset tracking, elevators, access control systems, and facility logistics because value is increasingly measured by time saved per shift, fewer manual handling injuries, improved task reliability, and better patient throughput.

Another transformative shift is the movement from hardware procurement to robotics-as-a-service and managed service models. Subscription-based deployment can lower upfront capital pressure and allow providers to scale units across departments. At the same time, cybersecurity, interoperability, infection control, battery performance, fleet management, and human factors design have become central purchasing criteria as robotic systems operate closer to patients, protected health information, and regulated care environments.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the impact of robotic nurse assistants by enabling autonomous navigation, voice interaction, predictive task routing, anomaly detection, computer vision, multilingual patient engagement, and adaptive workflow coordination. AI allows robots to move beyond fixed routes and respond to changing hospital environments, including crowded hallways, elevator use, shifting ward priorities, and dynamic supply demands.

The cumulative impact is operational rather than purely futuristic: AI can prioritize transport tasks, support remote patient observation, flag fall-risk behavior, improve uptime through predictive maintenance, and generate auditable workflow data for clinical and facilities teams. However, adoption depends on validated performance, explainable decision support, privacy safeguards, cybersecurity resilience, and clear clinical governance. In regulated healthcare settings, AI-enabled robotic nurse assistants must support nurses, document actions reliably, and maintain human oversight for all care-critical decisions.

Key Regional Insights

North America remains an early adopter of robotic nurse assistant solutions due to advanced hospital infrastructure, high labor costs, strong digital health investment, and sustained pressure from nursing workforce shortages. The United States leads deployments in acute care logistics, telepresence, disinfection support, and patient monitoring, while Canada's large geography and aging population support use cases in remote care coordination and hospital workflow automation. Europe benefits from public-sector modernization, strong medical device regulation, and workforce aging pressures, with the European Union's data protection and AI governance expectations shaping procurement standards for safe, interoperable healthcare robotics.

Asia-Pacific is a major innovation and adoption hub, led by Japan's super-aging demographics, South Korea's robotics capability and connectivity infrastructure, China's scale in automation and hospital modernization, India's expanding healthcare capacity, and Australia's need to serve geographically dispersed populations. Latin America is advancing selectively through private hospital networks and higher-acuity urban care centers in Brazil and Mexico, where automation is evaluated around productivity and premium care delivery. The Middle East, especially GCC health systems, is investing in smart hospitals, digital front doors, and automation-enabled patient experience, while Africa remains earlier-stage, with practical adoption focused on telepresence, logistics, training support, and workforce-extension models where connectivity, maintenance capacity, and procurement funding permit.

Key Group Insights

ASEAN markets are gaining attention as hospital networks in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines expand digital care capacity, although adoption varies by reimbursement, infrastructure maturity, clinical staffing models, and local technical support. The GCC is a high-potential group because national health transformation programs across Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman emphasize smart hospitals, automation, medical tourism, and premium patient experience supported by digitally enabled facilities.

The European Union is influential because its medical device, data privacy, cybersecurity, and AI rules set global expectations for safe deployment of robotic nurse assistant technologies. BRICS countries combine large patient populations with industrial policy ambitions, particularly in China and India, while Brazil and South Africa highlight the role of private hospital systems and access-focused care models. G7 markets account for many advanced deployments because of capital availability, aging demographics, mature hospital IT, and regulatory clarity. NATO members' dual-use robotics expertise also indirectly supports innovation in autonomous navigation, operational resilience, cybersecurity, remote operations, and secure communications that can transfer into healthcare robotics environments.

Key Country Insights

The United States represents the strongest near-term opportunity among the listed countries, supported by hospital automation budgets, workforce shortages, mature digital infrastructure, and broad use of clinical information systems. Canada's adoption is supported by aging demographics, remote care requirements, and publicly funded health system productivity priorities, while Mexico and Brazil show potential through private hospital chains, urban specialty care centers, and medical tourism corridors. The United Kingdom is focused on health system productivity and workforce relief, and Germany, France, Italy, and Spain are driven by aging populations, rehabilitation needs, hospital modernization, and European regulatory harmonization that supports safer procurement of connected medical technologies.

Russia's market is constrained by procurement complexity, budget pressures, and sanctions-related technology access, although domestic automation needs remain across large hospital networks. China is scaling healthcare robotics through manufacturing strength, automation policy support, hospital modernization, and rapid digital health adoption. India is driven by hospital bed expansion, staffing gaps, and growing private healthcare investment, while Japan remains a pioneer because of age-related care demand, long-term care pressure, and deep robotics experience. Australia needs automation across geographically dispersed care systems and remote service models, and South Korea combines robotics manufacturing, advanced connectivity, smart hospital adoption, and strong engineering capacity to support robotic nurse assistant deployment.

Actionable Recommendations for Industry Leaders

Industry leaders should begin with high-frequency, lower-risk workflows such as specimen transport, medication delivery, linen movement, meal delivery, disinfection support, fall-risk monitoring, telepresence rounding, and supply replenishment. These use cases can produce measurable operational value because they reduce walking time, improve task reliability, limit avoidable staff exposure, and allow nurses to focus on assessment, care planning, medication administration, and patient communication.

Executives should require evidence-based pilots with baseline and post-deployment metrics, including nurse time saved, task completion rates, response time, safety incidents, patient satisfaction, staff acceptance, uptime, cybersecurity performance, integration performance, and total cost of ownership. Vendors should prioritize interoperability, service support, clinical change management, human-centered design, and co-design with nurses. Buyers should also establish governance for AI validation, privacy, escalation protocols, infection prevention, maintenance responsibility, and staff training before scaling robotic nurse assistant platforms across facilities.

Research Methodology

This executive summary is based on secondary research, industry triangulation, and analysis of healthcare automation trends across hospitals, long-term care, rehabilitation, and home-adjacent care settings. Inputs include publicly available data from organizations such as the World Health Organization, national labor and health agencies, medical device regulators, data protection authorities, robotics industry bodies, peer-reviewed literature, and hospital technology adoption reports.

The methodology prioritizes verified indicators over speculative forecasts: workforce shortages, population aging, hospital capacity, digital health maturity, regulatory readiness, procurement models, infrastructure preparedness, and use-case economics. Regional, group, and country insights were evaluated through comparative assessment of healthcare infrastructure, robotics capabilities, reimbursement environments, data governance, clinical workflow readiness, cybersecurity requirements, and readiness for AI-enabled healthcare robotics integration.

Conclusion

Robotic nurse assistants are becoming a practical response to structural healthcare challenges rather than a replacement for human nurses. Their strongest value lies in automating repetitive, physically demanding, and logistics-heavy tasks while strengthening patient monitoring, telepresence, infection prevention support, and clinical workflow coordination.

The next phase of adoption will favor solutions that are safe, interoperable, AI-enabled, cybersecure, and measurable in operational outcomes. Providers that align robotics deployment with nurse experience, patient safety, workforce resilience, and digital governance will be best positioned to capture productivity gains. Technology providers that prove reliability, integration, service quality, and clinical trust will shape the competitive future of the robotic nurse assistant market.

Product Code: MRR-AD36CD897F83

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Robotic Nurse Assistant Market, by Component

7.1. Hardware
- 7.1.1. Actuators
- 7.1.2. Sensors
- 7.1.3. Wearable Robotics
- 7.1.4. Stationary Robotic Workstations
7.2. Services
- 7.2.1. Installation
- 7.2.2. Maintenance
- 7.2.3. Training
7.3. Software
- 7.3.1. Clinical Workflow Integration Software
- 7.3.2. AI-based Decision Support Systems
- 7.3.3. Fleet Management Software
- 7.3.4. Remote Monitoring & Teleoperation Software

8. Robotic Nurse Assistant Market, by Mobility

8.1. Stationary
8.2. Tracked
8.3. Wheeled

9. Robotic Nurse Assistant Market, by Autonomy Level

9.1. Fully Autonomous
9.2. Semi-Autonomous

10. Robotic Nurse Assistant Market, by Application

10.1. Medication Management
- 10.1.1. Adherence Monitoring
- 10.1.2. Dispensing
10.2. Logistics
- 10.2.1. Supply Transport
- 10.2.2. Waste Disposal
10.3. Patient Monitoring
- 10.3.1. Fall Detection
- 10.3.2. Vital Signs Monitoring
10.4. Rehabilitation
- 10.4.1. Cognitive Therapy Assistance
- 10.4.2. Physical Therapy Assistance
10.5. Telepresence
- 10.5.1. Remote Consultation
- 10.5.2. Remote Surgery Assistance

11. Robotic Nurse Assistant Market, by End User

11.1. Clinics
11.2. Home Healthcare
11.3. Hospitals
11.4. Long-Term Care Facilities

12. Robotic Nurse Assistant Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Robotic Nurse Assistant Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Robotic Nurse Assistant Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Concentration Analysis, 2025
- 15.1.1. Concentration Ratio (CR)
- 15.1.2. Herfindahl Hirschman Index (HHI)
15.2. Recent Developments & Impact Analysis, 2025
15.3. Product Portfolio Analysis, 2025
15.4. Benchmarking Analysis, 2025

16. Company Profiles

16.1. ABB Ltd.
16.2. Aethon Inc.
16.3. CYBERDYNE Inc.
16.4. Diligent Robotics
16.5. Ekso Bionics Holdings, Inc.
16.6. F&P Robotics AG
16.7. Fraunhofer-Gesellschaft
16.8. Honda Motor Co., Ltd.
16.9. Hstar Technologies Corp.
16.10. Intuition Robotics Ltd.
16.11. KUKA AG
16.12. LG Electronics Inc.
16.13. PAL Robotics S.L.
16.14. Panasonic Holdings Corporation
16.15. Relay Robotics, Inc.
16.16. Richtech Robotics Inc.
16.17. Samsung Electronics Co., Ltd.
16.18. SoftBank Robotics Group Corp.
16.19. Toyota Motor Corporation
16.20. UBTECH Robotics Corp.